Scheme 1.
Development of bioactive and lung-targeted Ber-lipo for enhanced murine ALI therapy through maintaining the homeostasis of macrophage polarization via inhibiting the activation of the TLR4/MyD88/NF-κB signaling pathway.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.